CRC progression may be associated with HuR’s ability to stabilize mRNAs encoding proteins involved in the cell cycle (e.g., cyclins, CDKs, and apoptosis resistance proteins, such as the Bcl-2 family) and epithelial-mesenchymal transition (EMT) genes. This evidence concerns the gene ELAVL1 and colorectal carcinoma.